Ezra Klein highlights a little discussed feature of the bill:

[H]ospitals will have to post prices. Insurance products will be presented with standardized information, consumer ratings and quality measures. The payments physicians take from drug and device companies will be in a public database. There will be independent funding for research on the relative effectiveness of different treatments. Some of these changes are small and some are big, but put together, the system is going to become a lot more visible in the coming years.

We want to hear what you think about this article. Submit a letter to the editor or write to letters@theatlantic.com.